Valeant Pharmaceuticals Intern...
NYSE: VRX
Here is a calendar of a few of the biggest companies expecting clinical trial and FDA updates in the month of October.
4 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Friday include Bookings Holdings, Dollar General, KLA-Tencor, Micron Technology, Nike and Red Hat.
4 years ago
Last Updated: 3 years ago
Valeant Pharmaceuticals shares were down over 5% in premarket trading Monday after the FDA failed to approve the company's lotion intended to treat plaque psoriasis.
4 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Wednesday include Alkermes, Cigna, International Paper, Medtronic, Tesla and Western Digital.
4 years ago
Last Updated: 10 months ago
The top analyst upgrades, downgrades and other research calls from Tuesday include CBS, Ford, Pivotal Software, Spotify, Symantec and Ulta Beauty.
5 years ago
Last Updated: 3 years ago
There is deep value for long-term investors in these specialty pharmaceutical companies, and the ability to buy in to some of the best companies in the industry at rock bottom pricing.
5 years ago
Last Updated: 3 years ago
Valeant Pharmaceuticals released its most recent quarterly report and announced a name change before the markets opened on Tuesday.
5 years ago
Last Updated: 3 years ago
24/7 Wall St. has put together a preview of Disney, Nvidia, Valeant Pharmaceuticals and of some of the other top companies reporting their latest results in the coming week.
5 years ago
Last Updated: 3 years ago
Here 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates in May.
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Friday include Archer Daniels Midland, Boeing, Hess, LogMeIn, NetApp, Sunrun, United Continental, Valeant Pharmaceuticals and XPO...
5 years ago
Last Updated: 3 years ago
These six additions to the Deutsche Bank Conviction List are top stocks to buy for the next year for growth accounts looking to add new positions.
5 years ago
Last Updated: 3 years ago
Valeant Pharmaceuticals saw its shares make a handy gain on Monday after Deutsche Bank upgraded the stock.
5 years ago
Last Updated: 3 years ago
The top analyst upgrades, downgrades and other research calls from Monday include AMAG Pharmaceuticals, Foot Locker, Groupon, H&R Block, McDonald's, Teradata, Under Armour and Valeant...
5 years ago
Last Updated: 3 years ago
Valeant Pharmaceuticals shares tumbled after it reported its most recent quarterly results early Wednesday.
5 years ago
Last Updated: 3 years ago
24/7 Wall St. has put together a preview of Square, Valeant Pharmaceuticals and some of the other top companies reporting their latest results in the coming week.
5 years ago
Last Updated: 3 years ago